Effects of a low dose of indapamide, a diuretic, given daily or every-other-day on blood pressure and metabolic parameters

被引:18
作者
Inaba, M [1 ]
Noguchi, Y [1 ]
Yamamoto, T [1 ]
Imai, T [1 ]
Hatano, M [1 ]
Yagi, S [1 ]
Katayama, S [1 ]
机构
[1] Saitama Med Sch, Dept Med 4, Kawagoe, Saitama 3500495, Japan
关键词
hypertension; indapamide; low dose diuretic treatment; metabolic parameters; ambulatory blood pressure monitoring;
D O I
10.1291/hypres.27.141
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
To investigate the effects of the diuretic, indapamide, on blood pressure (BP) and metabolic parameters, thirty hypertensive patients were treated with 1 mg of indapamide either every day or every other day. BP, fasting plasma glucose, lipids, serum potassium and uric acid were determined at baseline and after 3 months of a stable regimen of the drug. At the termination of the study, 48-h ambulatory blood pressure monitoring (ABPM) was performed. Three patients received only indapamide, while other patients were treated in combination with additional antihypertensive medications. Patients treated with daily indapamide showed a BP reduction from 162+/-2.9/85+/-2.4 mmHg to 134+/-2.4/71+/-2.6 mmHg (p<0.001). The BP reduction was similar in those patients receiving the drug every other day (137+/-3.4/71+/-3.6 mmHg). While plasma lipids and serum potassium did not differ significantly with the intervention, uric acid increased significantly with daily treatment and normalized with every-other-day treatment. Glycosylated hemoglobin A(1c) (HbA(1c)) was not altered (5.6+/-0.1% vs. 5.4+/-0.2%), and did not differ between patients with and without diabetes mellitus. ABPM revealed an average 24-h BP of 134+/-3.3/75+/-1.7 mmHg on days in which patients received the medication and 139+/-4.9/78+/-2.6 mmHg on the intervening day without indapamide (no significant difference). These results suggest that a low dose of indapamide given every day or every other day is effective in lowering BP and does not result in metabolic derangements.
引用
收藏
页码:141 / 145
页数:5
相关论文
共 21 条
[1]  
*ALLHAT OFF COORD, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981
[2]  
[Anonymous], 1991, JAMA, V265, P3255
[3]  
BABA S, 1982, GERIATR MED, V20, P1207
[4]  
Black HR, 1997, ARCH INTERN MED, V157, P2413
[5]   Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT) [J].
Brown, MJ ;
Palmer, CR ;
Castaigne, A ;
de Leeuw, PW ;
Mancia, G ;
Rosenthal, T ;
Ruilope, LM .
LANCET, 2000, 356 (9227) :366-372
[6]  
CAMPBELL DB, 1976, BRIT J CLIN PHARMACO, V3, pP971
[7]   RELATION BETWEEN DOSE OF BENDROFLUAZIDE, ANTIHYPERTENSIVE EFFECT, AND ADVERSE BIOCHEMICAL EFFECTS [J].
CARLSEN, JE ;
KOBER, L ;
TORPPEDERSEN, C ;
JOHANSEN, P .
BRITISH MEDICAL JOURNAL, 1990, 300 (6730) :975-978
[8]  
Chalmers J, 1999, J HYPERTENS, V17, P151
[9]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[10]   Hypokalemia associated with diuretic use and cardiovascular events in the systolic hypertension in the elderly program [J].
Franse, LV ;
Pahor, M ;
Di Bari, M ;
Somes, GW ;
Cushman, WC ;
Applegate, WB .
HYPERTENSION, 2000, 35 (05) :1025-1030